• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 12 May 2026

IFA: Increasing Target Price on Monster Q1 Revenue and Profitability


iFabric Corp. (IFA:TSE) | 0 0 (-7.2%) | Mkt Cap: 81.1m


  • Atrium Research
    • Nicholas Cortellucci, CFA

    • 7 pages


 

• IFA reported Q1 financials that beat our estimates across the board with revenue of $27.5M (+288% YoY), compared to our estimates of $25.1M. • Adjusted EBITDA came in at $5.7M (21% margin) vs. our $1.0M and well-beyond management’s past commentary on profitability. • Given the positive momentum on both growth and margins for 2026 and beyond, we are increasing our estimates, now aligning with management’s new targets for margins. Our new target is $7.50/share based on the same 18.0x 2027E EBITDA. This morning, iFabric Corp. (IFA:TSX, IFABF:OTCQX) announced its Q1/26 financial results that exceeded both our expectations and the high end of guidance, with revenue of $27.5M (+288% YoY) and Adjusted EBITDA of $5.7M (21% margin). The quarter was led by the Intelligent Fabrics segment ramping the Doctors Choice scrubs and Roots footwear program, alongside the Nudish intimate apparel launch at U.S. retailers. We have increased our estimates for the remainder of 2026 and 2027. We remind readers that we initiated coverage on IFA last month. Read the report here. We are maintaining a BUY rating and increasing our target price to $7.75/share (previously $4.50/share) on IFA. Q1 Financial Highlights • Revenue came in at a record $27.5M (+288% YoY), beating our estimate of $25.1M and the corporate guidance of $25-27M (upped from $20-25M). This was comprised of $3.9M in Intimate Apparel revenue (+212% YoY) and $23.6M from Intelligent Apparel revenue (+305% YoY). • The growth in revenue was led by medical scrubs, the new footwear programs, and the rebranding of the intimate apparel product lines. Furthermore, IFA’s core products benefited from increased store count penetration. • Revenue by geography breaks down into $10.5M from Canada (+141% YoY), $16.0M from the U.S. (+859% YoY), and $1.0M from Asia and other (-1% YoY). The U.S. was the standout, reflecting both the Nudish launch at major U.S. retailers, where the brand is no longer restricted to product categories. • Gross margin was 33%, above our estimate of 31% but down from 39% in Q1/25. Compression was driven by product mix (a higher proportion of lower-margin Intelligent Fabrics products) and increased U.S. tariffs on Chinese imports, which IFA is attempting to recover $850K from. • Adjusted EBITDA was $5.7M, largely beating our forecast of $1.0M. This represented a 21% EBITDA margin compared to 4% in Q1/25. SG&A increased 61% YoY due to increased royalties, commissions, personnel, advertising, etc. • Net income of $3.7M, smashing our estimate of $0.6M. EPS was $0.122/share compared to $0.003/share in Q1/25. • OCF before WC was $4.5M; however, A/R increased by $15.6M QoQ, leading to negative OCF and FCFF in the quarter. • IFA ended the quarter with $1.8M in cash vs. $3.8M in Q4. Total debt increased to $13.2M, translating to net debt to 2026E EBITDA of 1.2x.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

IFA: Increasing Target Price on Monster Q1 Revenue and Profitability


iFabric Corp. (IFA:TSE) | 0 0 (-7.2%) | Mkt Cap: 81.1m


  • Published: 12 May 2026
  • Author: Nicholas Cortellucci, CFA
  • Pages: 7
  • Atrium Research


• IFA reported Q1 financials that beat our estimates across the board with revenue of $27.5M (+288% YoY), compared to our estimates of $25.1M. • Adjusted EBITDA came in at $5.7M (21% margin) vs. our $1.0M and well-beyond management’s past commentary on profitability. • Given the positive momentum on both growth and margins for 2026 and beyond, we are increasing our estimates, now aligning with management’s new targets for margins. Our new target is $7.50/share based on the same 18.0x 2027E EBITDA. This morning, iFabric Corp. (IFA:TSX, IFABF:OTCQX) announced its Q1/26 financial results that exceeded both our expectations and the high end of guidance, with revenue of $27.5M (+288% YoY) and Adjusted EBITDA of $5.7M (21% margin). The quarter was led by the Intelligent Fabrics segment ramping the Doctors Choice scrubs and Roots footwear program, alongside the Nudish intimate apparel launch at U.S. retailers. We have increased our estimates for the remainder of 2026 and 2027. We remind readers that we initiated coverage on IFA last month. Read the report here. We are maintaining a BUY rating and increasing our target price to $7.75/share (previously $4.50/share) on IFA. Q1 Financial Highlights • Revenue came in at a record $27.5M (+288% YoY), beating our estimate of $25.1M and the corporate guidance of $25-27M (upped from $20-25M). This was comprised of $3.9M in Intimate Apparel revenue (+212% YoY) and $23.6M from Intelligent Apparel revenue (+305% YoY). • The growth in revenue was led by medical scrubs, the new footwear programs, and the rebranding of the intimate apparel product lines. Furthermore, IFA’s core products benefited from increased store count penetration. • Revenue by geography breaks down into $10.5M from Canada (+141% YoY), $16.0M from the U.S. (+859% YoY), and $1.0M from Asia and other (-1% YoY). The U.S. was the standout, reflecting both the Nudish launch at major U.S. retailers, where the brand is no longer restricted to product categories. • Gross margin was 33%, above our estimate of 31% but down from 39% in Q1/25. Compression was driven by product mix (a higher proportion of lower-margin Intelligent Fabrics products) and increased U.S. tariffs on Chinese imports, which IFA is attempting to recover $850K from. • Adjusted EBITDA was $5.7M, largely beating our forecast of $1.0M. This represented a 21% EBITDA margin compared to 4% in Q1/25. SG&A increased 61% YoY due to increased royalties, commissions, personnel, advertising, etc. • Net income of $3.7M, smashing our estimate of $0.6M. EPS was $0.122/share compared to $0.003/share in Q1/25. • OCF before WC was $4.5M; however, A/R increased by $15.6M QoQ, leading to negative OCF and FCFF in the quarter. • IFA ended the quarter with $1.8M in cash vs. $3.8M in Q4. Total debt increased to $13.2M, translating to net debt to 2026E EBITDA of 1.2x.

More Content

More Content

IFA: Explosive Revenue Growth Signals Multi-Year Runway in Medical Scrubs

Companies: iFabric Corp.

Atrium Research

VNCE: Snapping the Store: Staying Cool in Summer Heat; Reiterate Buy, $7 PT

Companies: PVH VNCE GPS URBN ITX ANF RL AEO AEO GES ITX VNCE ANF RL PVH URBN

Small Cap Consumer Research LLC

VRA: Snapping the Store: Ready for Summer, Sales; Reiterate Hold

Companies: VRA TPR TPR VRA

Small Cap Consumer Research LLC

LightInTheBox Holding:Proprietary brands provide momentum in Q126

Companies: Lightinthebox Holding Co Ltd-ADR (LITB:NYSE)LightInTheBox Holding Co., Ltd. Sponsored ADR (LITB:NYS)

Edison

AKA: 1Q Review: Pivoting to Growth; Reiterate Buy, $30 PT

Companies: GPS URBN ITX ANF AEO AEO GES ITX ANF AKA URBN

Small Cap Consumer Research LLC
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2026

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Allenby Capital
      • Alternative Resource Capital
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Morphose Capital Partners
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS Research Group
      • RBC Capital Markets
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Curious Compounder
      • The Edge Group
      • The Investor Summit
      • The Life Sciences Division
      • ThinkFront
      • Ticker TV
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Venn Brown
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • AlphaValue
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In